Digital Therapeutics Alliance

“Founding members digital therapeutics companies tech companies pharma companies”

“Each member does not have representation on the board. Only seven board members who are voted on by the full membership have representation.”

“No materially adverse change shall be made to the rights and privileges of any class of individual members, voting or nonvoting, including but not limited to: (a) voting rights except as required by law, (b) diminution of membership rights and privileges except those that apply to all classes of individual members in an equitable manner, or (c) additional or different requirements to attain or maintain membership in a class of individual members without the affirmative vote of more than two-thirds (2/3) of the votes of the members of the class of individual members so affected (whether otherwise voting or nonvoting members) cast at a meeting of members at which a quorum of members entitled to vote is present.”

“The form 990 is prepared by an outside accountant and e-mailed to each board member for review and comment before its filing.”

“When encountering potential conflicts of interest, members shall identify the potential conflict and notify the executive director. Specifically, individuals shall: "avoid placing (and avoid the appearance of placing) one's own self- interest above that of dta. While the receipt of incidental personal benefit may necessarily flow from certain dta activities, such benefit must be merely incidental to the primary benefit of dta and its purposes; -not abuse their position by improperly using it for services, dta's staff services, equipment, materials, or property for their personal or private business gain or pleasure, and shall not represent to third parties that their authority as a member and representative of the organization extends any further than that which it actually extends; -not engage in or facilitate any discriminatory or harassing behavior directed toward dta employees, officers, directors, members, suppliers, contractors, partners, or others in the context of activities relating to dta; -not solicit or accept large gifts, gratuities, free trips, honoraria, personal property, or any other item of value from any person or entity as a direct or indirect inducement to provide special treatment to such donor with respect to matters pertaining to dta without prior approval of the board of directors; "provide goods or services to dta as a paid vendor only after full disclosure to, and advance approval by, the board or executive director, and pursuant to any related procedures adopted by the board; -not persuade or attempt to persuade any member, exhibitor, advertiser, sponsor, subscriber, supplier, contractor, or any other person or entity with a relationship to or with dta to terminate or curtail its relationship to or with dta, or to in any way reduce the monetary or other benefits to dta of such relationship; and "upon termination of service, participants will promptly return to dta all documents, electronic and hard files, reference materials, and other property not already on file with dta. Such return will not abrogate him or her from the continuing obligations of confidentiality with respect to the information acquired as a consequence of his or her tenure.”

“Comparable data with board of director approval”

“Articles of incorporation and bylaws were made available to the general public during the tax year with the submission of form 1024 application for recognition of exemption under section 501(a).”

“Dta's mission is to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics with patients, clinicians, payors, policymakers through education, advocacy, and cross-industry collaboration.”